These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 30610857)
1. Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance. Yu J; Chen H; Jiang L; Wang J; Dai J; Wang J J Pharm Sci; 2019 May; 108(5):1788-1799. PubMed ID: 30610857 [TBL] [Abstract][Full Text] [Related]
2. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance. Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509 [TBL] [Abstract][Full Text] [Related]
3. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells. Zhang Z; Xu S; Wang Y; Yu Y; Li F; Zhu H; Shen Y; Huang S; Guo S J Colloid Interface Sci; 2018 Jan; 509():47-57. PubMed ID: 28881205 [TBL] [Abstract][Full Text] [Related]
4. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity. Tang J; Zhang L; Gao H; Liu Y; Zhang Q; Ran R; Zhang Z; He Q Drug Deliv; 2016 May; 23(4):1130-43. PubMed ID: 25491241 [TBL] [Abstract][Full Text] [Related]
5. Reversal of P-glycoprotein-mediated multidrug resistance by doxorubicin and quinine co-loaded liposomes in tumor cells. Shen Q; Qiu L J Liposome Res; 2017 Dec; 27(4):293-301. PubMed ID: 27581212 [TBL] [Abstract][Full Text] [Related]
6. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition. Gao M; Xu Y; Qiu L J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110 [TBL] [Abstract][Full Text] [Related]
7. Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer. Lv L; Liu C; Chen C; Yu X; Chen G; Shi Y; Qin F; Ou J; Qiu K; Li G Oncotarget; 2016 May; 7(22):32184-99. PubMed ID: 27058756 [TBL] [Abstract][Full Text] [Related]
8. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation. Li S; Zhao Q; Wang B; Yuan S; Wang X; Li K Phytother Res; 2018 Aug; 32(8):1530-1536. PubMed ID: 29635751 [TBL] [Abstract][Full Text] [Related]
9. pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells. Gao Y; Jia L; Wang Q; Hu H; Zhao X; Chen D; Qiao M ACS Appl Mater Interfaces; 2019 May; 11(18):16296-16310. PubMed ID: 30997984 [TBL] [Abstract][Full Text] [Related]
10. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559 [TBL] [Abstract][Full Text] [Related]
11. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells. Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039 [TBL] [Abstract][Full Text] [Related]
12. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein. Jin Y; Zhang Z; Zhao T; Liu X; Jian L J Biomed Nanotechnol; 2015 Aug; 11(8):1330-8. PubMed ID: 26295136 [TBL] [Abstract][Full Text] [Related]
13. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer. Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704 [TBL] [Abstract][Full Text] [Related]
14. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799 [TBL] [Abstract][Full Text] [Related]
15. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle. Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184 [TBL] [Abstract][Full Text] [Related]
17. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy. Kang XJ; Wang HY; Peng HG; Chen BF; Zhang WY; Wu AH; Xu Q; Huang YZ Acta Pharmacol Sin; 2017 Jun; 38(6):885-896. PubMed ID: 28479604 [TBL] [Abstract][Full Text] [Related]
18. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin. Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321 [TBL] [Abstract][Full Text] [Related]
19. Quercetin overcomes colon cancer cells resistance to chemotherapy by inhibiting solute carrier family 1, member 5 transporter. Zhou Y; Zhang J; Wang K; Han W; Wang X; Gao M; Wang Z; Sun Y; Yan H; Zhang H; Xu X; Yang DH Eur J Pharmacol; 2020 Aug; 881():173185. PubMed ID: 32422185 [TBL] [Abstract][Full Text] [Related]
20. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes]. Wang JC; Liu XY; Lü WL; Lee HS; Goh BC; Zhang Q Yao Xue Xue Bao; 2005 May; 40(5):475-80. PubMed ID: 16220797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]